<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C.&nbsp;20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">___________</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>___________</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;<B>Pursuant
To Section 13 OR 15(d) Of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event
reported): &nbsp;&nbsp;March 17, 2014</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FUTUREWORLD
ENERGY, INC.&nbsp;</B></FONT><BR>
<FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in charter)</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42%; font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 27%; font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>000-1273988</B></FONT></TD>
    <TD STYLE="width: 31%; font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black"><B>81-0562883</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(Commission File Number)</FONT></TD>
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(I.R.S. Employer Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">FutureWorld Energy, Inc.</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>3637 4<SUP>th</SUP> Street North,
        330<BR>
        Saint Petersburg, Florida</B></P></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black"><B>33704</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt/115% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(239) 324-0000</B><BR>
&nbsp;(Registrant&rsquo;s telephone number, including area code)</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:<BR>
<BR>
<BR>
<BR>
</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; line-height: 115%"><FONT STYLE="font: 10pt Wingdings; color: black">o</FONT></TD>
    <TD STYLE="width: 8%; line-height: 115%">&nbsp;</TD>
    <TD STYLE="width: 91%; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Wingdings; color: black">o</FONT></TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Wingdings; color: black">o</FONT></TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Wingdings; color: black">o</FONT></TD>
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 13.5pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 13.5pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">FORWARD LOOKING STATEMENTS</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">This Form 8-K and other reports filed by Registrant from
time to time with the Securities and Exchange Commission (collectively the &quot;Filings&quot;) contain or may contain forward
looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management
as well as estimates and assumptions made by Registrant's management. When used in the filings the words &quot;anticipate&quot;,
&quot;believe&quot;, &quot;estimate&quot;, &quot;expect&quot;, &quot;future&quot;, &quot;intend&quot;, &quot;plan&quot; or the
negative of these terms and similar expressions as they relate to Registrant or Registrant's management identify forward looking
statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties,
assumptions and other factors relating to Registrant's industry, Registrant's operations and results of operations and any businesses
that may be acquired by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions
prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Although Registrant believes that the expectations reflected
in the forward looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance or
achievements. Except as required by applicable law, including the securities laws of the United States, Registrant does not intend
to update any of the forward-looking statements to conform these statements to actual results.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 8.01. Other Events</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On March 3rd, 2014, the Board of Directors authorized the
establishment of an advisory board (the &quot;Advisory Board&quot;). The Advisory Board shall have the responsibility of advising
the Board of Directors and management of the Company regarding the Company's development of its business plan and IP in relations
to Industrial Hemp, Medical Marijuana, and Cannabis Related Pharmaceuticals &amp; Nutraceuticals. We believe domain experts are
the fundamental growth catalyst of our company and our business in the burgeoning markets of Industrial Hemp and Medical Marijuana.
The advisory board establishment is a prelude to HempTech&rsquo;s new division. We will continue building our strength in our divisions
by selecting industry leaders for our advisory board.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On March 14, 2014, the Company entered into those certain
advisory board agreements (collectively, the &quot;Advisory Board Agreements&quot;) with our first member of the advisory board
reflected below (collectively, the &quot;Advisory Board Members&quot;). In accordance with the terms and provisions of the Advisory
Board Agreements: (i) the Company shall retain each Advisory Board Member for a period commencing upon execution of the Advisory
Board Agreement and continuing until notice of termination provided by either party; and (ii) the Advisory Board Member shall provide
services to the Company including, but not limited, to: (a) participation in monthly advisory calls and annual meeting, and (b)
guidance on Industrial Hemp, Medical Marijuana, and Cannabis Related Pharmaceuticals &amp; Nutraceuticals strategy directions.
In further accordance with the terms and provisions of the Advisory Board Agreements, the Company shall grant to each Advisory
Board Member 150,000 stock options to purchase 150,000 shares of the Company's common stock at an exercise price of $0.03 per share,
which stock options shall vest as follows: (i) 150,000 stock options exercisable on the 12th month anniversary of the acceptance.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Initial Advisory Board Member</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Drs. Frans Trouwen has worked in the Life Science industry
since 2002. He has worked as the Chief Executive Officer of Valletta Health Holding, a spin off Biotech Company from the Academic
Medical Hospital in Amsterdam (Netherlands) from 2002 until 2011. From 2009 till 2011 he has also worked as the Managing Director
of Medical Accel Group (The Medical Accel Group offered scouting, screening, developing and sales of (bio) medical compounds and/or
devices both on a global level). Drs. Trouwen will be an instrumental figure for the development of Pharmaceuticals &amp; Nutraceuticals
sector of the Company.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">http://www.hemptechcorp.com</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The FutureWorld Energy Facebook Page (https://www.facebook.com/futureworldenergy)</P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">The
FutureWorld Energy Twitter Feed (https://twitter.com/</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">futureworldinc)</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">FutureWorld Energy, Inc.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Sam Talari</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Sam Talari</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Principal Executive Officer</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Dated: &nbsp;March 17 2014</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">&nbsp;</P>


</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "fwdghempadvisors317.htm", "secsgml_size_bytes": 16290}]
{"company-data": {"conformed-name": "FUTUREWORLD ENERGY, INC..", "cik": "0001273988", "assigned-sic": "7371", "irs-number": "810562883", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-112110", "film-number": "14696235"}, "business-address": {"street1": "6365 53RD. STREET NORTH", "city": "PINELLAS PARK", "state": "FL", "zip": "33781", "phone": "650-648-9508"}, "mail-address": {"street1": "6365 53RD. STREET NORTH", "city": "PINELLAS PARK", "state": "FL", "zip": "33781"}, "former-company": [{"former-conformed-name": "Futureworld Energy, Inc.", "date-changed": "20090409"}, {"former-conformed-name": "HATHAWAY CORP", "date-changed": "20031219"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
FORM 8-K
___________
CURRENT REPORT
Pursuant
To Section 13 OR 15(d) Of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):   March 17, 2014
FUTUREWORLD
ENERGY, INC.
(Exact name of registrant as specified in charter)
Delaware
000-1273988
81-0562883
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
FutureWorld Energy, Inc.
3637 4
th
Street North,
        330
Saint Petersburg, Florida
33704
(Address of principal executive offices)
(Zip Code)
(239) 324-0000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
FORWARD LOOKING STATEMENTS
This Form 8-K and other reports filed by Registrant from
time to time with the Securities and Exchange Commission (collectively the "Filings") contain or may contain forward
looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management
as well as estimates and assumptions made by Registrant's management. When used in the filings the words "anticipate",
"believe", "estimate", "expect", "future", "intend", "plan" or the
negative of these terms and similar expressions as they relate to Registrant or Registrant's management identify forward looking
statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties,
assumptions and other factors relating to Registrant's industry, Registrant's operations and results of operations and any businesses
that may be acquired by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions
prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.
Although Registrant believes that the expectations reflected
in the forward looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance or
achievements. Except as required by applicable law, including the securities laws of the United States, Registrant does not intend
to update any of the forward-looking statements to conform these statements to actual results.
Item 8.01. Other Events
On March 3rd, 2014, the Board of Directors authorized the
establishment of an advisory board (the "Advisory Board"). The Advisory Board shall have the responsibility of advising
the Board of Directors and management of the Company regarding the Company's development of its business plan and IP in relations
to Industrial Hemp, Medical Marijuana, and Cannabis Related Pharmaceuticals & Nutraceuticals. We believe domain experts are
the fundamental growth catalyst of our company and our business in the burgeoning markets of Industrial Hemp and Medical Marijuana.
The advisory board establishment is a prelude to HempTech's new division. We will continue building our strength in our divisions
by selecting industry leaders for our advisory board.
On March 14, 2014, the Company entered into those certain
advisory board agreements (collectively, the "Advisory Board Agreements") with our first member of the advisory board
reflected below (collectively, the "Advisory Board Members"). In accordance with the terms and provisions of the Advisory
Board Agreements: (i) the Company shall retain each Advisory Board Member for a period commencing upon execution of the Advisory
Board Agreement and continuing until notice of termination provided by either party; and (ii) the Advisory Board Member shall provide
services to the Company including, but not limited, to: (a) participation in monthly advisory calls and annual meeting, and (b)
guidance on Industrial Hemp, Medical Marijuana, and Cannabis Related Pharmaceuticals & Nutraceuticals strategy directions.
In further accordance with the terms and provisions of the Advisory Board Agreements, the Company shall grant to each Advisory
Board Member 150,000 stock options to purchase 150,000 shares of the Company's common stock at an exercise price of $0.03 per share,
which stock options shall vest as follows: (i) 150,000 stock options exercisable on the 12th month anniversary of the acceptance.
Initial Advisory Board Member
Drs. Frans Trouwen has worked in the Life Science industry
since 2002. He has worked as the Chief Executive Officer of Valletta Health Holding, a spin off Biotech Company from the Academic
Medical Hospital in Amsterdam (Netherlands) from 2002 until 2011. From 2009 till 2011 he has also worked as the Managing Director
of Medical Accel Group (The Medical Accel Group offered scouting, screening, developing and sales of (bio) medical compounds and/or
devices both on a global level). Drs. Trouwen will be an instrumental figure for the development of Pharmaceuticals & Nutraceuticals
sector of the Company.
http://www.hemptechcorp.com
The FutureWorld Energy Facebook Page (https://www.facebook.com/futureworldenergy)
The
FutureWorld Energy Twitter Feed (https://twitter.com/
futureworldinc)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
FutureWorld Energy, Inc.
/s/ Sam Talari
Sam Talari
Principal Executive Officer
Dated:  March 17 2014